Sarvear Pharmaceuticals U.A. manufactures Beta-Lactam and Cephalosporin dry-powder injectables, tablets, capsules and syrups for domestic, export and franchise partners — backed by a Schedule M–GMP certified plant in Selaqui, Dehradun.
Sarvear Pharmaceuticals U.A. is the parent manufacturing entity. Sympar Lifesciences is our dedicated PCD division. Both are backed by the same Schedule M–GMP certified plant and the same five decades of pharmaceutical craftsmanship.
Third-party and loan-licence manufacturing of Beta-Lactam and Cephalosporin dry-powder injectables, tablets and oral solids for pharma companies across India and 20+ export markets.
Monopoly-based PCD pharma franchise opportunities across India. 100+ formulations spanning cephalosporin range, injectables, tablets, capsules, syrups and general medicines.
Sarvear Pharmaceuticals U.A. manufactures the following formulations for third-party, loan-licence and export supply. Human and veterinary molecules available across multiple strengths.
Beta-Lactam & Cephalosporin — 15 molecules
Cephalosporin range — 13 molecules
Large-animal formulations — 7 molecules
Cephalosporin range, Beta-Lactam antibiotics, injectables, tablets, capsules, syrups, drops, soft gels and general medicines — all manufactured at our Selaqui plant. Browse the full interactive catalogue with search and filters.
Real shots from our 30,000+ sq. ft. Schedule M–GMP certified plant — production floor, sterile block, and Quality Control laboratory.
Production Floor · Selaqui
Sterile & Aseptic Block
QC LaboratoryEvery batch of tablets and dry-powder injectable undergoes comprehensive quality testing using validated analytical methods before release. Every product reflects our commitment to patient safety, quality and consistency.
Tell us about your requirement — a member of our commercial team will respond within one business day with next steps, documentation checklist and a preliminary quotation.